Lilly must divest Sentinel products after FTC nod on Novartis deal

December 22, 2014 4:55 PM

4 0

Lilly must divest Sentinel products after FTC nod on Novartis deal

WASHINGTON (Reuters) - Eli Lilly and Co has won approval to buy Novartis AG's animal health unit on condition that it divests its Sentinel line of products for treating heartworm in dogs, the Federal Trade Commission said on Monday.

The French company Virbac SA will buy the Sentinel product line now owned by Novartis Animal Health, the FTC said.

Read more

To category page

Loading...